Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH notice announces an update to terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    0.4%
    Check dated 2026-10-25T05:28:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T04:46:01.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer now identifies the software as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T06:42:05.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The footer revision tag was updated from v3.6.6 to v3.7.0, signaling a platform software update to the history view. It does not modify the recorded study data or history entries.
    Difference
    0.1%
    Check dated 2026-09-20T03:06:29.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.5 to v3.6.6, reflecting an administrative refresh of the record history. This is a metadata change rather than a substantive update to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T23:41:12.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision label in the record history changed from v3.6.4 to v3.6.5, indicating a new revision entry was added. This change affects only the metadata shown in the history and does not alter the study data or results.
    Difference
    0.0%
    Check dated 2026-08-08T23:31:23.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.